Apple Scores GlaxoSmithKline Study in Key Test of Health Apps
- Glaxo is the first drugmaker to use Apple’s ResearchKit
- Success of the trial will determine Glaxo’s future adoption
This article is for subscribers only.
GlaxoSmithKline Plc has started a rheumatoid arthritis study using Apple Inc.’s ResearchKit, marking the first time a drugmaker has used the health system for the iPhone to conduct clinical research.
Glaxo wants to record the mobility of 300 participants over three months and will also ask the patients to input both physical and emotional symptoms, such as pain and mood. The app Glaxo created from ResearchKit comes with a guided wrist exercise that uses the phone’s sensors to record motion, giving the drugmaker a standardized measurement across all users. The company will use the results to help design better clinical trials.